Adolescent Acute Lymphoblastic Leukemia: A Retrospective Single-Center Experience
dc.authorid | Ezgi Paslı Uysalol / 0000-0001-9357-4588 | |
dc.authorid | Cengiz Bayram / 0000-0003-2153-0628 | |
dc.authorid | Nihal Özdemir / 0000-0002-3204-4353 | |
dc.authorid | Sibel Akpınar Tekgündüz / 0000-0003-4937-1681 | |
dc.authorid | Gönül Aydoğan / 0000-0002-3805-531X | |
dc.authorid | Ali Ayçiçek / 0000-0001-8951-4750 | |
dc.authorscopusid | Nihal Özdemir / 57208780173 | |
dc.authorwosid | Nihal Özdemir / AAO-9962-2020 | |
dc.contributor.author | Uysalol, Ezgi Paslı | |
dc.contributor.author | Bayram, Cengiz | |
dc.contributor.author | Özdemir, Nihal | |
dc.contributor.author | Tekgündüz, Sibel Akpınar | |
dc.contributor.author | Aydoğan, Gönül | |
dc.contributor.author | Ayçiçek, Ali | |
dc.date.accessioned | 2025-04-18T09:30:05Z | |
dc.date.available | 2025-04-18T09:30:05Z | |
dc.date.issued | 12.09.2024 | |
dc.department | İstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | |
dc.description.abstract | Objective: Acute lymphoblastic leukemia (ALL) is one of the most common malignant diseases in children. This study aimed to determine the clinical and prognostic characteristics of adolescent patients with ALL aged 15–18 years who were followed up in our center. Materials and Methods: The clinical and laboratory characteristics, treatment responses, and survival and relapse rates of adolescent patients with ALL were retrospectively analyzed Results: The majority of patients were male. The median age of patients was 16 (range 15–17.9) years. About 36% and 74% of patients were diagnosed with T- and B-cell ALLs, respectively. Then, 32% of patients were stratified in the high-risk group. BCR/ABL t (9;22) positivity was detected in one patient. Recurrence was observed in 6 of 31 patients after completing the treatment. The estimated survival rate in the high-risk group at 32 months was 58%. Conclusion: Ihe prognosis and outcomes of ALL in adolescent and young adult patients are poor compared to younger age groups. Future clinical trials and advance in chemotherapeutic protocols in this age group will help increase the treatment success rates. | |
dc.identifier.citation | UYSALOL, E. P., BAYRAM, C., ÖZDEMIR, N., TEKGUNDUZ, S. A., AYDOĞAN, G., AYCICEK, A. (2023). Adolescent Acute Lymphoblastic Leukemia: A Retrospective Single-Center Experience. Çocuk Dergisi , 23(3), 63 - 67. doi.org/10.26650/jchild.2023.1341346 | |
dc.identifier.doi | 10.26650/jchild.2023.1341346 | |
dc.identifier.endpage | 67 | |
dc.identifier.issn | 1302-9940 | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 63 | |
dc.identifier.trdizinid | 1261803 | |
dc.identifier.uri | https://search.trdizin.gov.tr/tr/yayin/detay/1261803/adolescent-acute-lymphoblastic-leukemia-a-retrospective-single-center-experience | |
dc.identifier.uri | https://doi.org/10.26650/jchild.2023.1341346 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/6806 | |
dc.identifier.volume | 23 | |
dc.identifier.wos | WOS:001318931600009 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | TR-Dizin | |
dc.institutionauthor | Özdemir, Nihal | |
dc.institutionauthorid | Nihal Özdemir / 0000-0002-3204-4353 | |
dc.language.iso | en | |
dc.publisher | İstanbul Üniversitesi | |
dc.relation.ispartof | Çocuk Dergisi | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | adolescent | |
dc.subject | leukemia | |
dc.subject | survival | |
dc.title | Adolescent Acute Lymphoblastic Leukemia: A Retrospective Single-Center Experience | |
dc.title.alternative | Adolesan Akut Lenfoblastik Lösemileri: Geriye Dönük Tek Merkez Deneyimi | |
dc.type | Article |
Dosyalar
Lisans paketi
1 - 1 / 1
Küçük Resim Yok
- İsim:
- license.txt
- Boyut:
- 1.17 KB
- Biçim:
- Item-specific license agreed upon to submission
- Açıklama: